QQ客服 官方微博 反馈留言

	PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules
	Geng, Qiaohong; Jiao, Peifu; Jin, Peng; Su, Gaoxing; Dong, Jinlong; Yan, Bing
刊名	CURRENT PHARMACEUTICAL DESIGN
	2017
卷号	23期号:39页码:6033-6041
关键词	Cancer immunotherapy therapeutic antibody small molecules peptides structure-activity relationships tumor cells
DOI	10.2174/1381612823666171004120152
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4684361
专题	山东大学
作者单位	1.Qilu Normal Univ, Dept Chem, Jinan 250013, Shandong, Peoples R China. 2.Shandong Univ, Sch Envir
推荐引用方式 GB/T 7714	Geng, Qiaohong,Jiao, Peifu,Jin, Peng,et al. PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules[J]. CURRENT PHARMACEUTICAL DESIGN,2017,23(39):6033-6041.
APA	Geng, Qiaohong,Jiao, Peifu,Jin, Peng,Su, Gaoxing,Dong, Jinlong,&Yan, Bing.(2017).PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules.CURRENT PHARMACEUTICAL DESIGN,23(39),6033-6041.
MLA	Geng, Qiaohong,et al."PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules".CURRENT PHARMACEUTICAL DESIGN 23.39(2017):6033-6041.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。